Nedisertib (M3814) Mechanism of Action: DNA-PK Inhibition in Cancer Cell Research

Nedisertib (M3814) MOA:Targeting DNA-PK/NHEJ Pathway for Radiosensitization in Solid Tumors

🎯 check Nedisertib (M3814) product page

Nedisertib is a potent, selective DNA-PK inhibitor. It affects DNA repair signaling by blocking NHEJ, promoting cell death.

Primary Applications and Mechanism of Action